COMMUNIQUÉS West-GlobeNewswire

GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit
28/09/2026
Chief Executive Officer Marc Hertz and Chief Scientific Officer Vipin Kumar to present on translating immune biology and clinical signals into novel therapeutic approaches for IPF LA JOLLA, CA, Sept. 28, 2026 (GLOBE [...]
Transactions under Novonesis’ share buyback program
28/09/2026
Please read the announcement in PDF Attachment 2026_19_Share_buyback
Lifecore Biomedical to be Acquired by Webster Equity Partners
28/09/2026
Lifecore Common Stockholders to Receive $6.28 per Share in Cash at Closing, Representing a 49.5% Premium Lifecore Series A Preferred Stockholders Will Receive Required “Conversion Amount” per Share in Cash at Closing [...]
Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
28/09/2026
Oral presentation to highlight early endoscopic improvement and evidence of PDE4 target engagement in fibrostenotic Crohn’s disease Three moderated posters to showcase gut-targeted exposure, favorable safety and [...]
CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®
28/09/2026
AI-assisted reading tool designed to aid physician review of small bowel capsule endoscopy studies performed due to suspected bleeding using the CapsoCam Plus® system SARATOGA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE [...]
Hyperion DeFi Supports D3’s Frontier Vault Launch, Bringing Internet Domain Priority Access to the Hyperliquid Ecosystem
28/09/2026
DALLAS, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced it has been named a launch partner for Frontier’s Hyperliquid Vault, a new membership [...]
EnerSyn Global Inc. Announces Second Nigeria Energy Investment: Lagos CNG Mother Station Project
28/09/2026
BETHESDA, MD, Sept. 28, 2026 (GLOBE NEWSWIRE) -- EnerSyn Global Inc. (Nasdaq: ESYN) ("ESYN" or the "Company," and formerly known as HWH International Inc.) announced plans today to add a second energy project. On [...]
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
28/09/2026
Substantially all planned REO 033 clinical sites are now activated, with multiple patients currently on study Company expects to have sufficient Part A data to provide an interim clinical update by year-end 2026 FDA [...]
MindRank Partners with 3SBio to Commercialize its AI-Designed Oral GLP-1 in China
28/09/2026
HANGZHOU, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- MindRank AI Ltd. ("MindRank") today announced that it has entered into a strategic commercialization agreement with Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd. (" [...]
Novonesis celebrates major expansion of West Allis production facility, strengthening North American dairy innovation and manufacturing
28/09/2026
Investment increases production capacity, supports booming consumer demand and reinforces Wisconsin's leadership in dairy biosolutions WEST ALLIS, Wis., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Novonesis , a global leader in [...]
Novo Nordisk A/S - share repurchase programme
28/09/2026
Bagsværd, Denmark, 28 September 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Powerful NeOnc Brain Cancer Pipeline Advances
28/09/2026
November 17 FDA Meeting Set to Discuss Dosing and Trial Size for Second Drug in Pipeline DENVER, Sept. 28, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is putting another [...]
A New International Medical Approach Aimed at Reversing Diabetes has Officially Launched in Shenzhen, China
28/09/2026
SHENZHEN, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Recently in Shenzhen, China, the Center for Integrative Medicine for Chronic Diseases and the Center for Natural Diabetes Therapy at Shenzhen Hengsheng Hospital—a [...]
Lift Therapeutics Appoints Eva Ehrnrooth as Executive Head of Clinical Development and Adds Chau Khuong to Board of Directors
28/09/2026
London, September 28, 2026 – Lift Therapeutics (‘Lift’ or ‘the Company’) today announced the appointment of Eva Ehrnrooth, MD, PhD, as Executive Head of Clinical Development and Chau Khuong to its Board of Directors. Dr [...]
Penn Medicine et IBA lancent une joint-venture pour accompagner le développement de la protonthérapie et des programmes de radio-oncologie dans le monde
28/09/2026
Une nouvelle offre de services d’experts afin d’aider les établissements de santé à développer, déployer et optimiser leurs programmes de protonthérapie et de radio-oncologie sur l’ensemble des soins PHILADELPHIE, [...]
Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
28/09/2026
New expert-led services platform will help healthcare providers develop, implement, and optimize proton therapy and advanced radiation oncology programs across the full care delivery lifecycle PHILADELPHIA, Pa., and [...]
Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update
28/09/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 28, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
JJP Biologics to Present Data Showing the Potential of Nebaprubart for Linear IgA Dermatosis (LAD) at Two Key Upcoming Scientific Conferences
28/09/2026
Positive interim data from Phase Ib proof-of-concept trial will be presented at the IPPF Scientific Symposium on Pemphigus and Pemphigoid and at EADV Congress 2026 Data positions nebaprubart as a potential therapy [...]
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2026 et fait un point sur ses activités
28/09/2026
11,1 millions d’euros de trésorerie au 30 juin 2026 ; horizon de financement confirmé jusqu’à fin décembre 2026 La Société poursuit activement ses interactions avec les investisseurs institutionnels aux États-Unis et en [...]

Pages